Growth Metrics

Scholar Rock Holding (SRRK) Common Equity (2017 - 2026)

Scholar Rock Holding's quarterly Common Equity came in at $276.0 million in Q1 2026, down 11.63% year-on-year from $312.3 million in Q1 2025, and up 12.43% quarter-over-quarter from $245.5 million in Q4 2025.

Scholar Rock Holding has reported Common Equity for 10 years, with the latest figure at $276.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Common Equity fell 11.63% year-over-year to $276.0 million; the trailing twelve-month figure through Mar 2026 stood at $276.0 million (down 11.63% YoY), and the FY2025 full-year result was $245.5 million, down 33.41% from the prior year.
  • Common Equity for Q1 2026 stood at $276.0 million, up from $245.5 million in the prior quarter.
  • The five-year high for Common Equity was $368.6 million in Q4 2024, with the low at $79.2 million in Q3 2024.
  • Average Common Equity over 5 years is $232.6 million, with a median of $233.3 million recorded in 2025.
  • Year-over-year, Common Equity slumped 52.77% in 2024 and surged 209.35% in 2025.
  • Tracing SRRK's Common Equity over 5 years: stood at $260.2 million in 2022, then declined by 13.46% to $225.2 million in 2023, then soared by 63.68% to $368.6 million in 2024, then tumbled by 33.41% to $245.5 million in 2025, then gained by 12.43% to $276.0 million in 2026.
  • The last three Common Equity figures came in at $276.0 million (Q1 2026), $245.5 million (Q4 2025), and $245.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -1.42 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 35.63 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.00 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 13.21 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - 276.01 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 276.01 Mn
Dec 31, 2025 245.49 Mn
Sep 30, 2025 245.00 Mn
Jun 30, 2025 233.29 Mn
Mar 31, 2025 312.33 Mn
Dec 31, 2024 368.63 Mn
Sep 30, 2024 79.20 Mn
Jun 30, 2024 133.62 Mn
Mar 31, 2024 182.77 Mn
Dec 31, 2023 225.22 Mn
Sep 30, 2023 167.67 Mn
Jun 30, 2023 202.50 Mn
Mar 31, 2023 228.65 Mn
Dec 31, 2022 260.24 Mn
Sep 30, 2022 293.27 Mn
Jun 30, 2022 329.51 Mn
Mar 31, 2022 171.32 Mn
Dec 31, 2021 172.07 Mn
Sep 30, 2021 187.26 Mn
Jun 30, 2021 216.66 Mn
Mar 31, 2021 240.54 Mn
Dec 31, 2020 260.77 Mn
Sep 30, 2020 62.98 Mn
Jun 30, 2020 82.17 Mn
Mar 31, 2020 98.65 Mn
Dec 31, 2019 112.90 Mn
Sep 30, 2019 121.79 Mn
Jun 30, 2019 128.96 Mn
Mar 31, 2019 97.52 Mn
Dec 31, 2018 106.62 Mn
Sep 30, 2018 102.34 Mn
Jun 30, 2018 111.61 Mn
Mar 31, 2018 -61.93 Mn
Dec 31, 2017 -53.52 Mn